Next Article in Journal
Sarcosine as a Potential Prostate Cancer Biomarker—A Review
Next Article in Special Issue
Serum Oxidant and Antioxidant Status Following an All-Out 21-km Run in Adolescent Runners Undergoing Professional Training—A One-Year Prospective Trial
Previous Article in Journal
Death Associated Protein Kinases: Molecular Structure and Brain Injury
Previous Article in Special Issue
Hormesis in Aging and Neurodegeneration—A Prodigy Awaiting Dissection
Int. J. Mol. Sci. 2013, 14(7), 13873-13892; doi:10.3390/ijms140713873
Review

(Healthy) Ageing: Focus on Iodothyronines

1,†
, 2,†
, 2
, 2
, 2
 and 1,*
Received: 17 May 2013; in revised form: 13 June 2013 / Accepted: 19 June 2013 / Published: 4 July 2013
(This article belongs to the Special Issue Oxidative Stress and Ageing)
View Full-Text   |   Download PDF [575 KB, uploaded 19 June 2014]   |   Browse Figure
Abstract: The activity of the thyroid gland diminishes during ageing, but a certain tissue reserve of T3 and its metabolites is maintained. This reserve is thought to play a regulatory role in energy homeostasis during ageing. This review critically assesses this notion. T3 was thought to act predominantly through pathways that require transcriptional regulation by thyroid hormone receptors (TRs). However, in recent years, it has emerged that T3 and its metabolites can also act through non-genomic mechanisms, including cytosolic signaling. Interestingly, differences may exist in the non-genomic pathways utilized by thyroid hormone metabolites and T3. For instance, one particular thyroid hormone metabolite, namely 3,5-diiodo-L-thyronine (T2), increases the activity of the redox-sensitive protein deacetylase SIRT1, which has been associated with improvements in healthy ageing, whereas evidence exists that T3 may have the opposite effect. Findings suggesting that T3, T2, and their signaling pathways, such as those involving SIRT1 and AMP-activated protein kinase (AMPK), are associated with improvements in diet-induced obesity and insulin resistance emphasize the potential importance of the thyroid during ageing and in ageing-associated metabolic diseases.
Keywords: thyroid; ageing; thyroid hormone action; non-genomic pathways thyroid; ageing; thyroid hormone action; non-genomic pathways
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

de Lange, P.; Cioffi, F.; Silvestri, E.; Moreno, M.; Goglia, F.; Lanni, A. (Healthy) Ageing: Focus on Iodothyronines. Int. J. Mol. Sci. 2013, 14, 13873-13892.

AMA Style

de Lange P, Cioffi F, Silvestri E, Moreno M, Goglia F, Lanni A. (Healthy) Ageing: Focus on Iodothyronines. International Journal of Molecular Sciences. 2013; 14(7):13873-13892.

Chicago/Turabian Style

de Lange, Pieter; Cioffi, Federica; Silvestri, Elena; Moreno, Maria; Goglia, Fernando; Lanni, Antonia. 2013. "(Healthy) Ageing: Focus on Iodothyronines." Int. J. Mol. Sci. 14, no. 7: 13873-13892.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert